Gilead Sciences, Inc. News, Gilead Sciences, Inc. Quote, GILD Quote

Gilead Sciences, Inc. (NQ:GILD) Delayed: 56.04 -0.43 (0.76%)	Trade Now!
Previous Close	$56.47	52 Week High	$79.37
Open	$57.00	52 Week Low	$39.21
Day High	$58.07	P/E	31.31
Day Low	$55.84	EPS	$1.79
Volume	9,900,977

May 21, 2013 04:32 PM EMA Approves MAA for Gilead's (GILD) Sofosbuvir
May 21, 2013 04:30 PM European Medicines Agency Validates Gilead’s Marketing Application for Sofosbuvir for the Treatment of Hepatitis C
May 17, 2013 04:05 PM Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday, May 20
May 17, 2013 01:00 PM UBS Survey Shows Signs of Strength for Gilead's (GILD) TAF
May 17, 2013 08:33 AM AbbVie (ABBV) Has Plenty More Tricks Up Its Sleeve - Barron's
May 15, 2013 06:30 PM Gilead Announces Response Data from Phase 2 Study of Idelalisib for Previously Untreated Chronic Lymphocytic Leukemia
May 15, 2013 10:54 AM Griffin's Blue Ridge Capital Enters CBS (CBS), Citigroup (C), Netflix (NFLX); Exits Apple (AAPL)
May 14, 2013 06:25 PM Form 4 GILEAD SCIENCES INC For: May 10 Filed by: WOLD OLSEN PER
May 14, 2013 06:24 PM Form 4 GILEAD SCIENCES INC For: May 10 Filed by: WILSON GAYLE E
May 14, 2013 06:24 PM Form 4 GILEAD SCIENCES INC For: May 10 Filed by: Whitley Richard James

May 2, 2013 04:10 PM Gilead Sciences, Inc. (GILD) Misses Q1 EPS by 2c; Reaffirms Outlook
Feb 4, 2013 04:07 PM Gilead Sciences, Inc. (GILD) Tops Q4 EPS by 2c
Oct 23, 2012 04:17 PM Gilead Sciences, Inc. (GILD) Tops Q3 EPS by 6c
Aug 27, 2012 05:02 PM Gilead Sciences (GILD) granted FDA approval for Quad pill, Stribild
Aug 2, 2012 10:38 AM Gilead Sciences (GILD) Surges As Bristol-Myers' (BMY) Hep C Drug Has Major Setback
Jul 26, 2012 04:09 PM Gilead Sciences, Inc. (GILD) Tops Q2 EPS by 4c
Apr 26, 2012 04:06 PM Gilead Sciences, Inc. (GILD) Misses Q1 EPS by 3c
Feb 2, 2012 04:08 PM Gilead Sciences, Inc. (GILD) Misses Q4 EPS by 8c, Sales Top Slightly
Nov 21, 2011 07:01 AM Gilead Sciences (GILD) to acquire Pharmasset (VRUS) for $137/share
Oct 27, 2011 04:06 PM Gilead Sciences, Inc. (GILD) Tops Q3 EPS by 1c, Sales Fall Inline

May 21, 2013 04:32 PM EMA Approves MAA for Gilead's (GILD) Sofosbuvir
May 17, 2013 01:00 PM UBS Survey Shows Signs of Strength for Gilead's (GILD) TAF
May 17, 2013 08:33 AM AbbVie (ABBV) Has Plenty More Tricks Up Its Sleeve - Barron's
May 15, 2013 10:54 AM Griffin's Blue Ridge Capital Enters CBS (CBS), Citigroup (C), Netflix (NFLX); Exits Apple (AAPL)
May 3, 2013 02:49 PM Notable 52-Week Highs and Lows of the Day 05/03: (AIG) (STX) (GILD) High; (DCTH) (ZAGG) (VCRA) Low
May 3, 2013 09:31 AM StreetInsider.com Pre-Open Movers 5/3: (PKT) (YRCW) (WTW) Higher; (DCTH) (VCRA) (LNKD) Lower (more...)
May 3, 2013 09:14 AM Needham & Company Boosts PT on Gilead Sciences (GILD) to $62
May 2, 2013 06:18 PM Streetinsider.com After-Hours Movers 05/02: (PKT) (INVN) (WTW) Higher; (ZAGG) (GUID) (LNKD) Lower (more...)
May 2, 2013 04:10 PM Gilead Sciences, Inc. (GILD) Misses Q1 EPS by 2c; Reaffirms Outlook
May 2, 2013 12:20 PM Streetinsider.com's Hot Lunchtime Reads 05/02: (MA) (LVS) (GLD) (GILD) (MBI)

May 21, 2013 04:30 PM European Medicines Agency Validates Gilead’s Marketing Application for Sofosbuvir for the Treatment of Hepatitis C
May 17, 2013 04:05 PM Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday, May 20
May 15, 2013 06:30 PM Gilead Announces Response Data from Phase 2 Study of Idelalisib for Previously Untreated Chronic Lymphocytic Leukemia
May 14, 2013 04:05 PM Gilead Sciences to Present at the Bank of America Merrill Lynch 2013 Health Care Conference on Wednesday, May 15
May 2, 2013 04:05 PM Gilead Sciences Announces First Quarter 2013 Financial Results
May 2, 2013 08:30 AM Gilead Reports Interim Data From Phase 2 LONESTAR Study
Apr 29, 2013 08:30 AM Gilead Receives Complete Response Letters from U.S. Food and Drug Administration for Elvitegravir and Cobicistat
Apr 25, 2013 04:30 PM Gilead Sciences to Release First Quarter 2013 Financial Results on Thursday, May 2, 2013
Apr 23, 2013 06:06 AM Data from Phase 3 Studies of Gilead’s Sofosbuvir for Hepatitis C
Apr 8, 2013 04:30 PM Gilead Submits New Drug Application to U.S. FDA for Sofosbuvir for the Treatment of Hepatitis C

May 14, 2013 06:25 PM Form 4 GILEAD SCIENCES INC For: May 10 Filed by: WOLD OLSEN PER
May 14, 2013 06:24 PM Form 4 GILEAD SCIENCES INC For: May 10 Filed by: WILSON GAYLE E
May 14, 2013 06:24 PM Form 4 GILEAD SCIENCES INC For: May 10 Filed by: Whitley Richard James
May 14, 2013 06:24 PM Form 4 GILEAD SCIENCES INC For: May 10 Filed by: Lofton Kevin E
May 14, 2013 06:23 PM Form 4 GILEAD SCIENCES INC For: May 10 Filed by: MADIGAN JOHN W
May 14, 2013 06:23 PM Form 4 GILEAD SCIENCES INC For: May 10 Filed by: HILLS CARLA A
May 14, 2013 06:23 PM Form 4 GILEAD SCIENCES INC For: May 10 Filed by: DAVIGNON ETIENNE
May 14, 2013 06:22 PM Form 4 GILEAD SCIENCES INC For: May 10 Filed by: Cogan John Francis
May 13, 2013 01:38 PM Form 8-K GILEAD SCIENCES INC For: May 08
May 10, 2013 07:38 PM Form 4 GILEAD SCIENCES INC For: May 08 Filed by: WOLD OLSEN PER

Entities mentioned with GILD